MARKET

IGC

IGC

IGC Pharma Inc
AMEX
0.2830
+0.0015
+0.53%
After Hours: 0.2850 +0.002 +0.71% 19:45 09/10 EDT
OPEN
0.2890
PREV CLOSE
0.2815
HIGH
0.2905
LOW
0.2810
VOLUME
623.94K
TURNOVER
--
52 WEEK HIGH
0.4508
52 WEEK LOW
0.2350
MARKET CAP
29.26M
P/E (TTM)
-3.7090
1D
5D
1M
3M
1Y
5Y
1D
'Federal Court Rejects Marijuana Opponents’ Request To Block Trump’s Rescheduling Move' - Marijuana Moment
Benzinga · 1d ago
Weekly Report: what happened at IGC last week (0831-0904)?
Weekly Report · 3d ago
Weekly Report: what happened at IGC last week (0824-0828)?
Weekly Report · 08/31 09:32
President And Founder Of Seabreeze Capital Partners LP Dougie Kass Posts On X "We have moved to super size $MSOS and individual cannabis stocks in the belief that a favorable rescheduling announcement will come shortly."
Benzinga · 08/28 17:49
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Dow Jones · 08/26 10:05
IGC Pharma Price Target Raised to $6.00/Share From $5.50 by Ascendiant Capital
Dow Jones · 08/26 10:05
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $6
Benzinga · 08/26 09:55
Acadia Pharmaceuticals: Another Bite At The Alzheimer's Apple
Seeking Alpha · 08/24 23:42
More
About IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) to develop treatments for Alzheimer's and metabolic disorders. The Company's lead asset, IGC-AD1, is a cannabinoid-based therapy is in a Phase 2 trial (CALMA) for agitation in Alzheimer's dementia. The Company’s pipeline includes TGR-63, targeting amyloid plaques, and early-stage programs focused on neurodegeneration, tau proteins, and metabolic dysfunctions. The Company integrates AI to accelerate drug discovery, optimize clinical trials, and enhance patient targeting. It is also developing a Multimodal Interpretable Transformer for Alzheimer’s Disease (MINT-AD). MINT-AD leverages diverse data sources, including brain scans, genetics, lifestyle, and cognitive metrics, to produce clinically interpretable risk profiles and forecast decline trajectories.

Webull offers IGC Pharma Inc stock information, including AMEX: IGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IGC stock methods without spending real money on the virtual paper trading platform.